---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-123880"
form_type: "8-K"
ticker: "INMB"
cik: "0001711754"
company_name: "Inmune Bio, Inc."
filed_at: "2025-12-19T23:59:59+00:00"
generated_at: "2026-05-16T12:35:39.224801+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# INmune Bio enters $65M ATM equity distribution agreement with A.G.P.

## Summary
- Up to $65M of common stock may be sold from time to time through A.G.P. as sales agent.
- Commission of 3.0% of gross proceeds; Company not obligated to sell any shares.
- Shares offered via shelf registration effective Aug 7, 2024, with prospectus supplement dated Dec 19, 2025.
- A.G.P. will use commercially reasonable efforts consistent with Nasdaq rules and state/federal law.

## SEC filing metadata
- accession: 0001213900-25-123880
- form_type: 8-K
- ticker: INMB
- cik: 0001711754
- company_name: Inmune Bio, Inc.
- filed_at: 2025-12-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711754/000121390025123880/0001213900-25-123880-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711754/000121390025123880/ea0269963-8k_inmune.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-123880
- JSON: https://secwatch.observer/filing/0001213900-25-123880.json
- Plain text: https://secwatch.observer/filing/0001213900-25-123880.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.